Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer

Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer

US Patent 9260519 · Granted Feb 16, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2019
Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors2019
Method for lysing a single cell in a solid tissue2018
Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer2017
Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer2017
Biomarker profiles for predicting outcomes of cancer therapy with ERBB3 inhibito2017
Pharmaceutical compositions comprising RET inhibitors and methods for the treatm2014
Screening for gestational disorders2008
Interface between substrates having microarrays and microtiter plates2006
Small molecule printing2004